Nomura Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-32,100
| Closed | -$3.94M | – | 1856 |
|
|
2025
Q4 | $3.94M | Hold |
32,100
| – | – | 0.01% | 864 |
|
|
2025
Q3 | $3.56M | Sell |
32,100
-169,600
| -84% | -$19.3M | 0.01% | 911 |
|
|
2025
Q2 | $22.4M | Buy |
201,700
+109,600
| +119% | +$11.7M | 0.05% | 232 |
|
|
2025
Q1 | $10.3M | Buy |
92,100
+87,100
| +1,742% | +$8.99M | 0.02% | 468 |
|
|
2024
Q4 | $462K | Buy |
+5,000
| New | +$450K | ﹤0.01% | 1826 |
|
|
2024
Q1 | – | Sell |
-28,100
| Closed | -$2.28M | – | 1777 |
|
|
2023
Q4 | $2.28M | Buy |
28,100
+5,400
| +24% | +$420K | 0.01% | 914 |
|
|
2023
Q3 | $1.7M | Buy |
+22,700
| New | +$1.75M | ﹤0.01% | 837 |
|
|
2023
Q1 | – | Sell |
-954,900
| Closed | -$79.9M | – | 1555 |
|
|
2022
Q4 | $79.9M | Buy |
+954,900
| New | +$75.6M | 0.33% | 59 |
|
|
2022
Q3 | – | Sell |
-700,000
| Closed | -$45.4M | – | 1800 |
|
|
2022
Q2 | $45.4M | Buy |
+700,000
| New | +$43.3M | 0.16% | 84 |
|
|
2020
Q2 | – | Sell |
-10,000
| Closed | -$742K | – | 1166 |
|
|
2020
Q1 | $742K | Buy |
+10,000
| New | +$691K | ﹤0.01% | 612 |
|
|
2019
Q2 | – | Sell |
-200,000
| Closed | -$13.2M | – | 1180 |
|
|
2019
Q1 | $13.2M | Buy |
200,000
+146,200
| +272% | +$9.72M | 0.06% | 256 |
|
|
2018
Q4 | $3.38M | Sell |
53,800
-7,300
| -12% | -$510K | 0.01% | 592 |
|
|
2018
Q3 | $4.74M | Hold |
61,100
| – | – | 0.02% | 500 |
|
|
2018
Q2 | $4.33M | Sell |
61,100
-23,900
| -28% | -$1.69M | 0.01% | 539 |
|
|
2018
Q1 | $6.46K | Sell |
85,000
-34,500
| -29% | -$2.74M | 0.01% | 507 |
|
|
2017
Q4 | $8.71M | Hold |
119,500
| – | – | 0.02% | 483 |
|
|
2017
Q3 | $9.72M | Buy |
119,500
+85,000
| +246% | +$6.5M | 0.02% | 385 |
|
|
2017
Q2 | $2.42M | Buy |
+34,500
| New | +$2.3M | 0.01% | 783 |
|
|
2017
Q1 | – | Sell |
-75,000
| Closed | -$5.46M | – | 1405 |
|
|
2016
Q4 | $5.46M | Hold |
75,000
| – | – | 0.01% | 540 |
|
|
2016
Q3 | $5.95M | Hold |
75,000
| – | – | 0.02% | 397 |
|
|
2016
Q2 | $6.29M | Buy |
75,000
+10,000
| +15% | +$887K | 0.02% | 383 |
|
|
2016
Q1 | $5.93M | Sell |
65,000
-35,000
| -35% | -$3.16M | 0.02% | 319 |
|
|
2015
Q4 | $10.1M | Buy |
+100,000
| New | +$10.4M | 0.03% | 251 |
|
|
2015
Q3 | – | Sell |
-25,000
| Closed | -$2.86M | – | 1748 |
|
|
2015
Q2 | $2.86M | Sell |
25,000
-2,775,000
| -99% | -$303M | 0.01% | 657 |
|
|
2015
Q1 | $272M | Sell |
2,800,000
-31,200
| -1% | -$3.17M | 0.89% | 10 |
|
|
2014
Q4 | $269M | Sell |
2,831,200
-17,400
| -0.6% | -$1.8M | 0.72% | 16 |
|
|
2014
Q3 | $299M | Sell |
2,848,600
-2,792,800
| -50% | -$273M | 0.81% | 22 |
|
|
2014
Q2 | $467M | Buy |
5,641,400
+5,503,100
| +3,979% | +$428M | 0.13% | 21 |
|
|
2014
Q1 | $9.9M | Buy |
+138,300
| New | +$10.8M | ﹤0.01% | 492 |
|
Other funds holding GILD
VCM
VPM
Nomura Holdings's GILD Position: Q1 2026 in Review
Nomura Holdings reduced its Gilead Sciences (GILD) stake by 37% in Q1 2026, selling an estimated $13.2M and leaving 161,713 shares worth $22.5M. The position accounts for 0.06% of the portfolio, ranked #216.
Nomura Holdings first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $63.7M in Q2 2019. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Nomura Holdings held 161,713 shares of Gilead Sciences worth $22.5M as of Q1 2026.
- Nomura Holdings sold 94,373 Gilead Sciences shares in Q1 2026, an estimated $13.2M.
- Gilead Sciences made up 0.06% of Nomura Holdings's portfolio in Q1 2026, its #216 holding.
- Nomura Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
- Nomura Holdings's Gilead Sciences position peaked at $63.7M in Q2 2019.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.